IP Library Granted Patent US 12,012,604
Granted Patent B2
US 12,012,604 · App. 17/347,204 · Granted Jun 18, 2024

Acetate consuming yeast cell

Inventors: Paul Klaassen (Echt, NL); Jozef Petrus Johannes Schmitz (Echt, NL); Paulus Petrus De Waal (Echt, NL); Arjen Bouma (Echt, NL)
Assignee: Danisco US Inc.
C12N15/81C12N9/0006C12N9/0008C12N9/1205C12N9/16C12N9/92C12N9/93C12P7/06C12P7/10C12Y102/0101C12Y207/01028C12Y207/01029C12Y301/03021C12Y503/01005C12Y602/01001C12P2203/00Y02E50/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,012,604
App. No.
17/347,204
Granted
Jun 18, 2024
Kind
B2
Abstract

The present invention relates to a yeast cell that is genetically modified comprising: a) a disruption of one or more aldehyde dehydrogenase (E.C:1.2.1.4) native to the yeast; b) one or more nucleotide sequence encoding a heterologous NAD+-dependent acetylating acetaldehyde dehydrogenase (E.C. 1.2.1.10); c) one or more nucleotide sequence encoding a homologous or heterologous acetyl-CoA synthetase (E.C. 6.2.1.1); and d) a modification that leads to reduction of glycerol 3-phosphate phosphohydrolase (E.C. 3.1.3.21) and/or glycerol 3-phosphate dehydrogenase (E.C. 1.1.1.8 or E.C. 1.1.5.3) activity, native to the yeast.

Claims (20)

1. A yeast cell that is genetically modified comprising:

a) a disruption of one or more aldehyde dehydrogenase (E.C:1.2.1.4) native to the yeast;

b) one or more nucleotide sequence encoding a heterologous NAD+-dependent acetylating acetaldehyde dehydrogenase (E.C. 1.2.1.10);

c) one or more nucleotide sequence encoding a homologous or heterologous acetyl-CoA synthetase (E.C. 6.2.1.1); and

d) a modification that leads to reduction of glycerol 3-phosphate phosphohydrolase (E.C. 3.1.3.21) and/or glycerol 3-phosphate dehydrogenase (E.C. 1.1.1.8 or E.C. 1.1.5.3) activity, native to the yeast.

2. The yeast cell according to claim 1 , wherein the one or more aldehyde dehydrogenase (E.C:1.2.1.4) native to the yeast in a) is an acetaldehyde dehydrogenase-6 (ALD6).

3. The yeast cell according to claim 1 , wherein the yeast cell comprises e) one or more nucleotide sequence encoding a heterologous xylose isomerase (E.C. 5.3.1.5).

4. The yeast cell according to claim 1 , wherein the yeast cell comprises a disruption of one or more of the genes gpp1, gpp2, gpd1 and gpd2 native to the yeast.

5. The yeast cell according to claim 1 , wherein the yeast cell comprises further:

f) one or more nucleotide sequence encoding a heterologous glycerol dehydrogenase (E.C. 1.1.1.6); and

g) one or more nucleotide sequence encoding a homologous or heterologous dihydroxyacetone kinase (E.C. 2.7.1.28 or E.C. 2.7.1.29).

6. The yeast cell according to claim 1 , wherein the yeast cell is a pentose and glucose fermenting yeast cell that is capable of anaerobic simultaneous pentose and glucose consumption.

7. A process for the fermentation of a yeast cell according to claim 1 , wherein the fermentation time for substantially complete fermentation of acetate, pentose and hexose is reduced relative to the corresponding fermentation of wild-type yeast.

8. The process according to claim 7 , wherein the fermentation time is reduced 40% or more.

9. The process according to claim 6 , wherein pentose and glucose are co-fermented.

10. The process according to any of claim 7 , wherein the overall ethanol production rate is at least about 20%, at least about 50% or about 100% higher than that of a process with the corresponding wild-type yeast.

11. The process according to claim 7 , wherein a hydrolysate of lignocellulosic material is fermented.

12. The process according to claim 11 , wherein the hydrolysate is an enzymatic hydrolysate of lignocellulosic material.

13. The process according to claim 11 , wherein the hydrolysate comprises acetate.

14. The process according to claim 13 , wherein the acetate comprising hydrolysate has an acetate concentration of 5% (w/w) or more.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 14, 2023
From: DSM IP ASSETS B.V.
To: DANISCO US INC.
Reel/Frame 066005/0848 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2021
From: KLAASSEN, PAUL; SCHMITZ, JOZEF PETRUS JOHANNES; DE WAAL, PAULUS PETRUS; BOUMA, ARJEN
To: DSM IP ASSETS B.V.
Reel/Frame 056547/0261 →
Priority Claims (1)
EP 15168833 · May 22, 2015 · regional
Continuity (2)
Continuation 15575538
Related Publication 20210310013A1 · Oct 7, 2021